论文部分内容阅读
目的:探讨口服避孕药(OCP)预处理在行IVF/ICSI中多囊卵巢综合征(PCOS)患者行拮抗剂方案中的效果。方法:回顾性分析行拮抗剂方案IVF/ICSI的92名PCOS患者的临床资料,按有无OCP预处理分为OCP+拮抗剂组(A组)和直接拮抗剂组(B组),比较A、B组患者的一般情况、促排卵情况和临床结局。结果:患者的一般情况、Gn使用天数、思则凯使用天数和使用量、受精率、卵裂率、可用胚胎率和优质胚胎率组间均无统计学差异(P>0.05)。A组总Gn使用量、获卵数略低于B组,A组临床妊娠率高于B组,但差异均无统计学意义(P>0.05)。B组发生1例中度卵巢过度刺激综合征(OHSS)。结论:PCOS患者拮抗剂方案促排卵前行OCP预处理有减少总Gn使用量、获卵数和提高临床妊娠率的趋势。
Objective: To investigate the effect of oral contraceptives (OCP) pretreatment in the treatment of patients with polycystic ovary syndrome (PCOS) in IVF / ICSI. Methods: The clinical data of 92 PCOS patients undergoing IVF / ICSI were retrospectively analyzed. The patients were divided into OCP + antagonist group (group A) and direct antagonist group (group B) B group of patients in general, ovulation promotion and clinical outcome. Results: There was no significant difference in the general condition of patients, the days of Gn use, the days of use and the amount of usage, the fertilization rate, cleavage rate, available embryo rate and good embryo rate (P> 0.05). The total Gn usage in Group A was slightly lower than that in Group B, while the clinical pregnancy rate in Group A was higher than that in Group B, but the difference was not statistically significant (P> 0.05). One case of moderate ovarian hyperstimulation syndrome (OHSS) occurred in group B. CONCLUSION: OCP pretreatment with antagonist regimen in patients with PCOS has the tendency to reduce the total Gn usage, the number of oocytes retrieved and the clinical pregnancy rate.